Jumo Health

Jumo Health is a Patient Experience Organization that specializes in optimizing clinical trial outcomes through patient readiness systems. The company works with 17 of the world's top 25 life science companies, including Pfizer, Novartis, Merck, and Eli Lilly, to address patient enrollment and retention challenges in clinical trials.

The company offers two primary solutions: CORE (Content for Recruitment & Education), which delivers expert-designed patient education materials that translate protocols into accessible language, and PRISM (Patient Readiness & Intelligence System), an infrastructure platform that assesses readiness across cognitive, emotional, behavioral, and burden domains using conversational AI. These solutions focus on preparing patients before enrollment rather than simply increasing recruitment volume.

Jumo Health positions itself as an alternative to traditional agencies, in-house teams, and CROs by establishing patient readiness as an operational discipline. The company's approach addresses the gap between patient eligibility and actual preparedness to complete trials, with a focus on complex, rare disease, and pediatric studies.

Organizations should consider Jumo Health when clinical trial timelines are consistently impacted by patient dropouts, screen failures, or enrollment volatility. The company's methodology is particularly relevant for sponsors dealing with complex protocols where patient understanding and emotional preparedness significantly impact completion rates.

Expect a consultative engagement that begins with a readiness and experience audit to identify specific failure points in the patient journey. The company's dual-product structure allows for either tactical content solutions or comprehensive readiness infrastructure depending on organizational needs and trial complexity.

Jumo Health operates exclusively in the clinical trial and pharmaceutical sector, specifically addressing patient experience challenges in drug development. The company's expertise centers on translating complex medical protocols into patient-accessible education while managing the emotional and behavioral dimensions of trial participation.

Their healthcare specialization extends to rare disease and pediatric trials, where patient preparation and caregiver engagement are particularly critical. The company works within the regulatory and operational constraints of clinical research, including site coordination and sponsor timelines.

Mid-to-large pharmaceutical companies and biotechnology firms conducting multi-site clinical trials in complex therapeutic areas. Organizations with recurring challenges in patient retention, screen failure rates, or site burden. Clinical operations leaders responsible for enrollment predictability and cost-per-completer metrics who can implement systematic patient experience infrastructure.